Vite 20¿
Natural health product licensed in Canada
- Licence holder
- Blaine Labs Inc.
- NPN or DIN-HM
- 80003350
- Status
- Active licence
- Licence date
- 7 May 2007
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| acide undécylénique | 10.2 % (p/p) |
Non-medicinal ingredients
Stéarate de PEG-100, Aloe barbadensis, Coco-caprylate, Huile d'arbre à thé, triéthanolamine, Huile de Lavandula angustifolia, Acide stéarique, Urée, Stéarate de glycéryle, Parahydroxybenzoate de méthyle, (p)-hydroxybenzoate de propyle, Eau, Hydroxyethyl Cellulose, EDTA de sodium, Polysorbate 60, Alcool cétylique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 12 years | Not specified | Not specified |
Uses authorised in Canada
For the treatment of jock itch (tinea crusis) or ringworm (tinea corporis). Relieves itching, burning, cracking and scaling which accompany these conditions.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
None known
- Contre-indications
None known
Source
Official Health Canada record, licence 80003350
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.